<< Back
Apr 23, 2015

Tandem Diabetes Care Announces Upcoming Conference Presentations

SAN DIEGO, April 23, 2015 (GLOBE NEWSWIRE) -- Tandem Diabetes Care®, Inc. (Nasdaq:TNDM), a medical device company and manufacturer of the t:slim® and t:flex™ Insulin Pumps, today announced that Kim Blickenstaff, president and CEO, will present a company update at the following upcoming investor conferences:

  • Deutsche Bank 40th Annual Health Care Conference, which will be held at the InterContinental Boston Hotel in Boston, Massachusetts on Wednesday, May 6, 2015 at 4:10pm Eastern Time (1:10pm Pacific Time).
  • Bank of America Merrill Lynch 2015 Health Care Conference, which will be held at the Encore at the Wynn Hotel in Las Vegas, Nevada on Wednesday, May 13, 2015 at 1:00pm Eastern Time (10:00am Pacific Time).

The presentations will be webcast live, and an archive recording will be available for 30 days. The links to the live webcasts and archives will be accessible on Tandem Diabetes Care's Investor Center website located at http://investor.tandemdiabetes.com in the "Investor Events" section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin. The Company manufactures the t:slim® Insulin Pump, the slimmest and smallest durable insulin pump currently on the market, and the t:flex™ Insulin Pump, the first pump designed for people with greater insulin requirements. Tandem is based in San Diego, California.

Follow Tandem Diabetes Care on Twitter @tandemdiabetes, use #tslim, #tconnect and $TNDM.

Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.

t:flex is a trademark, and t:slim and Tandem Diabetes Care are registered trademarks of Tandem Diabetes Care, Inc.

CONTACT: Media Contact:

         Steve Sabicer

         714-907-6264

         ssabicer@thesabicergroup.com



         Investor Contact:

         Susan Morrison

         858-366-6900 x7005

         smorrison@tandemdiabetes.com

Tandem Diabetes Care Logo

Source: Tandem Diabetes Care

News Provided by Acquire Media